Interleukin-17: A Putative Novel Pharmacological Target for PathologicalPain
Shao‐Jie Gao(Tongji Hospital), Jiayi Wu(Tongji Hospital), Dai-Qiang Liu(Tongji Hospital), Long-Qing Zhang(Tongji Hospital), Fan‐He Song(Tongji Hospital), Danyang Li(Qilu Hospital of Shandong University), Ya‐Qun Zhou(Tongji Hospital), Lin Liu(Tongji Hospital)
Cited by 11
Related Papers
Interleukin-6: an emerging regulator of pathological pain
|Journal of Neuroinflammation|2016|438
Carbon Monoxide and Its Controlled Release: Therapeutic Application, Detection, and Development of Carbon Monoxide Releasing Molecules (CORMs)
|Journal of Medicinal Chemistry|2017|316
PI3K/Akt Pathway: A Potential Therapeutic Target for Chronic Pain
|Current Pharmaceutical Design|2017|126
Sestrin2 overexpression attenuates osteoarthritis pain via induction of AMPK/PGC-1α-mediated mitochondrial biogenesis and suppression of neuroinflammation
|Brain Behavior and Immunity|2022|122
Role of curcumin in the management of pathological pain
|Phytomedicine|2018|117